The world's leading automated proofreading software

April 22, 2021

The Schlafender Hase Team

Risks of Converting Documents in the Pharmaceutical Industry

Data integrity. These are two words that are not easily confused or misinterpreted.  In any context, across continents, data integrity holds one meaning. That meaning lies in what the finalized document or work communicates and if this communication remains in an unaltered form over time.

Change, though philosophically defined as unavoidable, basically rocks assurance of any data integrity.

Human Error is a Leading Data Integrity Issue

Human error while recording data is a leading reason why conversions do not maintain the correct message. Even using computer systems to convert original data to different formats, therefore cutting out human imperfection, still will not guarantee perfectly replicated data.

Converted formats often:

    • Shift layouts

    • Skew fonts

    • Convert or replace fonts

    • Drop characters

    • Erase tables or pictures

    • Remove highlighting & comments

To catch these changes over formats, one must have a sharp eye.  This is where the professionals come in.

Regulatory Affairs Professionals Must See All

No change must go unseen is the mantra for Regulatory Affairs (RA) professionals when proofreading pharmaceutical documents.  Aware of the many changes that can happen when converting original data, RA professionals have learned over time and unfortunately, through trial and error, where issues most commonly occur.  The lucky RA professionals have the use of proofreading software to help find any discrepancies or changes. However, not all proofreading software is created equal.

With the importance on maintaining data integrity, it would go without saying that proofreading software should not convert the format of the documents to perform a comparison.  This, however, is not always the case.  Some proofreading software convert the documents to a different format for comparison.  As already mentioned, conversion results in one thing: loss of data integrity.

Unadulterated data is not a new concept for the FDA or other regulatory bodies, yet the FDA has increasingly observed CGMP violations involving data integrity during inspections.

The FDA Code of Federal Regulation 211.180 d) requires true copies or other accurate reproductions of the original records. Regulatory bodies around the world are increasingly focusing on data integrity problems throughout GMP processes, therefore utilising the right proofreading software is more crucial than ever.

How TVT Reduces Risk

  • Proof that data has remained in its original format when performing a comparison.

  • Integrated libraries for the compared documents from the document manufacturer themselves. (i.e.: MS Word libraries licensed from Microsoft.)

Here are two crucial questions you should ask:

  • Does your comparison or proofreading software convert text?

  • Does your provider use licensed libraries?

The team at Schlafender Hase understands how essential data integrity is and has designed TVT to work flawlessly without needing to alter the format of your documents. Are you looking for more on this subject? Read Why data integrity is important in pharma.

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Related Blogs

March 22, 2024

Schlafender Hase Team

Best Practices for your Promotional Review Process

The aim of a pharmaceutical promotional review process is to ensure the accuracy and compliance of promotional material with the relevant medical, legal, and regulatory aspects of a specific market.

March 18, 2024

Schlafender Hase Team

Ensuring Patient Safety: Medical Device Recall Process and Prevention Strategies

The costs of medical device recalls can run well into the millions of dollars. In terms of numbers of devices recalled, heading the unfortunate list of medical device recalls in recent times is a Class I recall of 38 million Vial2Bag fluid transfer systems by West Pharmaceuticals in 2019.

February 15, 2024

Schlafender Hase Team

Proofreading Regulated Documents in Pharma

Proofreading regulated documents in pharma presents unique challenges. Avoid the high risk of costly mistakes with best practices and by leveraging technology.